This is a correction to: Pataje G Prasanna, PhD, Deborah E Citrin, MD, Jeffrey Hildesheim, PhD, Mansoor M Ahmed, PhD, Sundar Venkatachalam, PhD, Gabriela Riscuta, MD, CNS, Dan Xi, PhD, Guangrong Zheng, PhD, Jan van Deursen, PhD, Jorg Goronzy, MD, PhD, Stephen J Kron, MD, PhD, Mitchell S Anscher, MD, Norman E Sharpless, MD, Judith Campisi, PhD, Stephen L Brown, PhD, Laura J Niedernhofer, MD, PhD, Ana O’Loghlen, PhD, Alexandros G Georgakilas, PhD, Francois Paris, PhD, David Gius, MD, PhD, David A Gewirtz, PhD, Clemens A Schmitt, MD, Mohamed E Abazeed, MD, PhD, James L Kirkland, MD, PhD, Ann Richmond, PhD, Paul B Romesser, MD, Scott W Lowe, PhD, Jesus Gil, PhD, Marc S Mendonca, PhD, Sandeep Burma, PhD, Daohong Zhou, MD, C Norman Coleman, MD, Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy, JNCI: Journal of the National Cancer Institute, Volume 113, Issue 10, October 2021, Pages 1285–1298, https://doi.org/10.1093/jnci/djab064
In the originally published version of this manuscript, grant funding from the Cancer Prevention and Research Institute of Texas for Dr Guis was omitted and has subsequently been added to the online version of the article. Additionally, Dr Guis’ affiliation has been updated to reflect his position at the time research was undertaken.